Resmed Inc (RMD) P/FCF 16.6 | Overview

Search global stocks & ETFs...Ctrl K

Learn Mode

Resmed IncRMD

$198.99

-$3.77 (-1.859%)

at close

4.36/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Updates

RMD

Stock Profile

Market Cap

Industry

EPS (TTM)

P/E (TTM)

Div & Yield

FCF Payout Ratio

P/S (TTM)

P/B

Revenue Growth (TTM)

EPS CAGR (3Y)

Diluted Shares

Ex-Dividend

Next Earnings

Forward P/E

Payout Ratio

P/FCF (TTM)

FCF Yield

Earnings Yield

Revenue CAGR (3Y)

Recommended Metric

Score Card

Explore Scores Tab

4.36

Very Good

Resmed Inc has grown revenue at 10.28% over the past year, which is strong growth. Also, it has more cash than current liabilities meaning it has enough cash to handle all its debts within the next year, if it wanted to.

Valuation Score

Key Score

4.00

Good

Management

2.00

Bad

Growth

3.00

Average

Profitability

3.00

Average

Fin. Health

5.00

Very Good

Dividends

1.00

Very Bad

Analyst

5.00

Very Good

Financials

Explore Financial Tab ›

Revenue

Earnings

Free Cash Flow

Insider Transactions

Explore Insider Tab ›

Buy Transactions

Sell Transactions

Peers

Select stocks to compare

ABTAbbott Laboratories

ZBHZimmer Biomet Holdings, Inc

$91.12

-2.81%

EWEdwards Lifesciences Corp

$85.73

-2.40%

GMEDGlobus Medical Inc

$77.00

-4.83%

BAXBaxter International Inc

$22.61

-3.17%

IDXXIdexx Laboratories Inc

GEHCGe Healthcare Technologies Inc

Price Targets & Ratings

View Analysis

1-year price targets, ending Jun 28, 2027

Current

$198.99

Baseline

High

$341.25

▲

71.49%

Avg

$265.85

▲

33.60%

Low

$181.80

▼

-8.64%

Analyst Ratings based on 25 Analysts

Strong Buy

16%

Buy

40%

Hold

36%

Sell

04%

Strong Sell

04%

About

Stock News

View All Updates